Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Leases Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Growth Metrics

Cresco Labs (CRLBF) Long-Term Investments (2019 - 2024)

Cresco Labs filings provide 4 years of Long-Term Investments readings, the most recent being $651000.0 for Q3 2024.

On a quarterly basis, Long-Term Investments changed N/A to $651000.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $651000.0, a N/A change, with the full-year FY2023 number at $730000.0, changed N/A from a year prior.
Long-Term Investments hit $651000.0 in Q3 2024 for Cresco Labs, down from $664000.0 in the prior quarter.
In the past five years, Long-Term Investments ranged from a high of $4.3 million in Q1 2022 to a low of $651000.0 in Q3 2024.
Median Long-Term Investments over the past 3 years was $730000.0 (2023), compared with a mean of $1.5 million.